Both in Pharmaceuticals
Alzamend Neuro vs Ensysce Biosciences
Over the past year ALZN returned −41.2% and ENSC returned −82.9%; their daily moves had a correlation of 0.18.
ALZN −41.2% ENSC −82.9%Growth of $1, one year, split-adjusted
| Metric | ALZN | ENSC |
|---|---|---|
| Price | $1.40 | $0.4049 |
| Market cap | $6.8M | $7.9M |
| Today | −19.08% | −2.62% |
| 1 month | −14.5% | +4.3% |
| 6 months | +37.3% | −26.0% |
| Year to date | −23.1% | −56.0% |
| 1 year | −41.2% | −82.9% |
| Revenue growth (YoY) | — | −15.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.8× |
| Net cash | $7.6M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 67.5% | 131.7% |
| Short % of float | 3.3% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).